Anitha Vijayan

Medicine & Life Sciences

1. Acute Kidney Injury 100%
2. Kidney 68%
3. Critical Illness 66%
4. Renal Replacement Therapy 61%
5. Coronavirus 43%
6. Poisoning 29%
7. Kidney Diseases 24%
8. Intermittent Renal Replacement Therapy 23%
9. Renal Dialysis 23%
10. Dialysis 23%
11. Systematic Reviews 21%
12. Living Donors 20%
13. Biomarkers 20%
14. Nephrology 19%
15. Continuous Renal Replacement Therapy 19%
16. Chronic Renal Insufficiency 18%
17. Mortality 16%
18. Intensive Care Units 16%
19. Tissue Donors 15%
20. Chronic Kidney Failure 15%
21. Therapeutics 14%
22. Precision Medicine 14%
23. Tissue and Organ Procurement 12%
24. abetimus 10%
25. Kidney Neoplasms 10%
26. Organ Dysfunction Scores 9%
27. Acute Disease 9%
28. Dialysis Solutions 9%
29. Insulin-Like Growth Factor I 9%
30. insulin-like growth factor binding protein-related protein 1 9%
31. Creatinine 8%
32. Multicenter Studies 8%
33. Confidence Intervals 8%
34. Kidney Transplantation 8%
35. Pyroptosis 8%
36. Hepatocyte Growth Factor 7%
37. Systemic Lupus Erythematosus 7%
38. ROC Curve 7%
39. endoplasmic reticulum glycoprotein p72 7%
40. Cohort Studies 7%
41. Transplants 7%
42. Risk Assessment 7%
43. Artificial Respiration 7%
44. Tumor Necrosis Factor Receptors 7%
45. Urine 7%
46. osteoblast cadherin 7%
47. Manuscripts 6%
48. Tissue Inhibitor of Metalloproteinase-2 6%
49. Atlases 6%
50. Biopsy 6%